Bulimia Nervosa (BN) is a serious disorder characterized by overvalued ideas concerning body weight and shape and disinhibited eating patterns consisting of extreme dieting followed by binge eating and purging. BN occurs in approximately 1-2% of the adolescent population, while clinically significant bulimic behaviors or partial BN (specifically defined as binge eating and purging on average at least once a week for six months ) occur in an additional 2-3%. However, other than frequency of binge eating and purging behaviors there appear to be few differences in the clinical severity of those with full syndrome BN and those with partial BN. Although bulimic behaviors typically onset during adolescence, there are only two published randomized clinical trials (RCTs) examining treatments for this age group. Results from our own recently published RCT of adolescent BN using a form of family-based therapy (FBT-BN) has shown that BN is superior to individual therapy for adolescents with BN. Also, recently published case series reports suggest that CBT adjusted for adolescents (CBT-A) is a promising treatment for bulimia in this age group.
The Specific Aims of the proposal are:
Aim 1 : To compare the efficacy of CBT-A to FBT-BN in decreasing binge eating and purging episodes in adolescents with BN and partial BN (defined as binge eating and purging at least one time per week for the past six months). We predict that subjects randomized to CBT-A will achieve abstinence (as assessed by the Eating Disorder Examination) at significantly higher rates than those who receive FBT- BN.
Aim 2 : To explore potential moderators of outcome. We predict that symptom severity at baseline will moderate outcome;specifically, those subjects with greater symptom severity (higher EDE subscale scores) will have better outcomes with CBT-A than FBT-BN.
Aim 3 : To explore potential mediators of outcome. We predict that early changes in the restraint subscale of the EDE-Q) will mediate outcome in both treatments.
Aim 4 : If there are no differences between the two specific treatments, we will explore abstinence differences between specific treatments (CBT-A and FBT-BN) compared to a non-specific treatment (Supportive psychotherapy - SPT) in order to examine nonspecific treatment effects (passage of time and nonspecific therapeutic influences). To accomplish these aims the following two-site study is proposed: 158 adolescents (79 at each site) between the ages of 12-18 years who meet DSM- IV criteria for BN or partial BN will be randomized to CBT-A (66 subjects), FBT-BN (66 subjects) or SPT (26 subjects), a non-specific treatment for BN for a 20 session/six month treatment period. The study is powered for the analysis of the primary aim of comparing the two specific treatments (FBT-BN and CBT-A);however, we are randomizing a smaller cohort to SPT to allow a post-hoc examination of non-specific treatment factors should no differences be found between the two specific treatments. Project Narrative This application is a proposal to conduct a randomized controlled trial of three psychosocial treatments for adolescent bulimia nervosa. To accomplish these aims the following two-site study is proposed: 158 adolescents (79 at each site) between the ages of 12-18 years who meet DSM-IV criteria for BN or BN-EDNOS (binge eating and purging episodes of a minimum frequency of 1 time per week for a minimum duration of 6 months) will be randomized to either CBT-A (n=66), family-based treatment-BN (n=66), or supportive psychotherapy (n=26).

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
3R01MH079979-02S1
Application #
7881041
Study Section
Special Emphasis Panel (ZMH1-ERB-D (06))
Program Officer
Sarampote, Christopher S
Project Start
2008-09-12
Project End
2013-05-31
Budget Start
2009-06-01
Budget End
2010-05-31
Support Year
2
Fiscal Year
2009
Total Cost
$56,082
Indirect Cost
Name
University of Chicago
Department
Psychiatry
Type
Schools of Medicine
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637
Valenzuela, Fabiola; Lock, James; Le Grange, Daniel et al. (2018) Comorbid depressive symptoms and self-esteem improve after either cognitive-behavioural therapy or family-based treatment for adolescent bulimia nervosa. Eur Eat Disord Rev 26:253-258
Goldschmidt, Andrea B; Crosby, Ross D; Cao, Li et al. (2018) Network analysis of pediatric eating disorder symptoms in a treatment-seeking, transdiagnostic sample. J Abnorm Psychol 127:251-264
Accurso, Erin C; Lebow, Jocelyn; Murray, Stuart B et al. (2016) The relation of weight suppression and BMIz to bulimic symptoms in youth with bulimia nervosa. J Eat Disord 4:21
Le Grange, Daniel; Lock, James; Agras, W Stewart et al. (2015) Randomized Clinical Trial of Family-Based Treatment and Cognitive-Behavioral Therapy for Adolescent Bulimia Nervosa. J Am Acad Child Adolesc Psychiatry 54:886-94.e2
Madden, S; Miskovic-Wheatley, J; Wallis, A et al. (2015) A randomized controlled trial of in-patient treatment for anorexia nervosa in medically unstable adolescents. Psychol Med 45:415-27
Darcy, Alison M; Fitzpatrick, Kathleen Kara; Manasse, Stephanie M et al. (2015) Central coherence in adolescents with bulimia nervosa spectrum eating disorders. Int J Eat Disord 48:487-93
Mann, Andrea P; Accurso, Erin C; Stiles-Shields, Colleen et al. (2014) Factors associated with substance use in adolescents with eating disorders. J Adolesc Health 55:182-7
Forsberg, Sarah; LoTempio, Elizabeth; Bryson, Susan et al. (2013) Therapeutic alliance in two treatments for adolescent anorexia nervosa. Int J Eat Disord 46:34-8
Le Grange, Daniel; Swanson, Sonja A; Crow, Scott J et al. (2012) Eating disorder not otherwise specified presentation in the US population. Int J Eat Disord 45:711-8
Klenotich, Stephanie J; Seiglie, Mariel P; McMurray, Matthew S et al. (2012) Olanzapine, but not fluoxetine, treatment increases survival in activity-based anorexia in mice. Neuropsychopharmacology 37:1620-31

Showing the most recent 10 out of 20 publications